Bumrungrad Hospital PCLBUGDF 100 Debt-to-EBITDA is 0.01 as of Mar. 2026, which is 96% below its 10-year median of 0.23. GuruFocus rates BUGDF with a GF Score™ of 100/100 and a GF Value™ of $5.29. The stock has 4 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Bumrungrad Hospital PCL ranks better than 99.79% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Bumrungrad Hospital PCL's Debt-to-EBITDA or its related term are showing as below:
BUGDF'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.01 Med: 0.23 Max: 0.96
Current: 0.01
During the past 13 years, the highest Debt-to-EBITDA Ratio of Bumrungrad Hospital PCL was 0.96. The lowest was 0.01. And the median was 0.23.
BUGDF's Debt-to-EBITDA is ranked better than 99.79% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 2.22
vs BUGDF: 0.01
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Bumrungrad Hospital PCL Debt-to-EBITDA Related Terms
Bumrungrad Hospital PCL Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Bumrungrad Hospital PCL's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bumrungrad Hospital PCL Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bumrungrad Hospital PCL's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Bumrungrad Hospital PCL's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Bumrungrad Hospital PCL (BUGDF) has a Debt-to-EBITDA of 0.01 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Bumrungrad Hospital PCL. This is 96% below median its historical median of 0.23. Over the past decade, Bumrungrad Hospital PCL's Debt-to-EBITDA has ranged from 0.01 to 0.96. According to the industry distribution chart, Bumrungrad Hospital PCL ranks #1 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 0.2%.
Is Bumrungrad Hospital PCL's Debt-to-EBITDA too high?
Bumrungrad Hospital PCL's current Debt-to-EBITDA of 0.01 is 96% below median its 10-year median of 0.23. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 0.96. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.22. Bumrungrad Hospital PCL's value of 0.01 is 99.5% below this industry median. Based on the distribution chart, Bumrungrad Hospital PCL ranks #1 out of 477 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Bumrungrad Hospital PCL has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Bumrungrad Hospital PCL's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bumrungrad Hospital PCL ranks #1 out of 477 companies for Debt-to-EBITDA. This places Bumrungrad Hospital PCL in the top 0% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.22. Bumrungrad Hospital PCL's value of 0.01 is 99.5% below this benchmark. Historically, Bumrungrad Hospital PCL's own Debt-to-EBITDA has ranged from 0.01 to 0.96 over the past decade. While the company's 10-year median is 0.23 vs. the industry median of 2.22, Bumrungrad Hospital PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.22, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bumrungrad Hospital PCL's current Debt-to-EBITDA of 0.01 is 99.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Bumrungrad Hospital PCL. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bumrungrad Hospital PCL's current Debt-to-EBITDA is 0.01, which is 96% below median its own 10-year median of 0.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bumrungrad Hospital PCL stock overvalued right now?
Bumrungrad Hospital PCL (BUGDF) has a current Debt-to-EBITDA of 0.01. The stock's GF Value™ is $5.29, compared to a current price of $4.75 — trading 10.2% below its estimated fair value. The current Debt-to-EBITDA is 0.01, which is 96% below median its 10-year median of 0.23 and 99.5% below the Healthcare Providers & Services industry median of 2.22. Bumrungrad Hospital PCL's overall GF Score™ is 100/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Bumrungrad Hospital PCL (BUGDF), the current Debt-to-EBITDA is 0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bumrungrad Hospital PCL (BUGDF) Overvalued in 2026?
Based on GuruFocus' analysis, Bumrungrad Hospital PCL stock appears to be undervalued.
The current stock price of $4.75 is trading 10.2% below its estimated GF Value™ of $5.29.
Key valuation signals for BUGDF:
Debt-to-EBITDA: 0.01 (96% below median its 10-year median of 0.23)
GF Value™: $5.29 vs. price of $4.75 (10.2% below fair value)
Industry Position: 99.5% below the Healthcare Providers & Services median (#1 of 477)
No single metric tells the full story. See the BUGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. The company operates several healthcare-related entities, within and outside of Thailand which include Bumrungrad International Hospital, Bumrungrad International Clinic, Vitallife Scientific Wellness Center, VitalLife Skin Clinic, Bumrungrad International Dialysis Clinic, and others. It is a healthcare provider in Thailand providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities. The company has only one main reportable operating segment, which is the hospital and health care center business, and the geographical area of its operations is Thailand.
100GF Score
Get the complete analysis for BUGDF
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUGDF has been successfully added to your 
